2014, № 12 (173)

Belyiy Yu.А., Novikov S.V., Kolesnik А.I., Yudina Yu.А. INTRAVITREAL IMPLANT FOR DRUG DELIVERY TO THE POSTERIOR SEGMENT STRUCTURES OF THE EYEDevelopment and experimental substantiation of the method of drug delivery to the structures of the posterior segment using biodegradable intravitreal implant are considered. The peculiarity of the implant is the possibility of alternation of saturated and unsaturated medicinal substance layers. During studying of process of degradation of unsaturated implant was found that the degradation of the polymer backbone of the implant was by hydrolysis. The proposed implant provides periodic selection of the active substance that prevents the excess of the therapeutic drug concentrations in the environment due to the design of the implant.Key words: delivery of medicines, the intravitreal implant.

Download

References:

1. Chakchir, B.A. Photometric methods of analysis: Methodological guidelines / B.A. Chakchir, G.M. Alekseeva. — SPb.: In SPFA, 2002. — 44 p.

2. Allen, T.M. Drug delivery systems: entering the mainstream / T.M. Allen, P.R. Cullis // Science. — 2004. — 303. — (5665). — P. 1818–1822.

3. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema / J.A. Cardillo [et al.] // Ophthalmology. — 2005. — 112. — P. 1557–1563.

4. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema / Y.J. Choi [et al.] // Korean J. Ophthalmol. — 2006. — 20. — P. 205–209.

5. Frederici, T.J. Intravitreal injections: AAO's Focal Points / T.J. Frederici // Clinical Modules for Ophthalmologists. — 2009. — 27. — No 8 (module 2). — P. 1–12.

6. Recent perspectives in ocular drug delivery / R. Gaudana [et al.] // Pharm Res. — 2009. — 26. — P. 1197–1216.

7. Hebson, C.B. A functional, nonfunctioning retisert implant / C.B. Hunter, S.K. Srivastava // Ocul Immunol. Inflamm. — 2011. — 19. — P. 210–211.

8. Hunter, R.S. Dexamethasone intravitreal implant for the treatment of noninfectious uveitis / R.S. Hunter, A.M. Lobo // Clinical Ophthalmology. — 2011. — 5. — P. 1613–1621.

9. Jaffe, G.J. Intraocular drug delivery / G.J. Jaffe, P. Ashton, P.A. Pearson // Taylor & Francis Group 270 Madison Avenue. — New York, NY 10016. — 2006. — P. 1–8.

10. Risks of intravitreous injection: a comprehensive review / R.D. Jager [et al.] // Retina. — 2004. — 24. — P. 676–698.

11. Biodegradable implants for sustained drug release in the eye / S.S. Lee [et al.] // Pharm. Res. — 2010. — 27. — P. 2043–2053.

12. Controlled drug delivery by biodegradable polyester devices: different preparative approaches / R. Jain [et al.] // Drug Development and Industrial Pharmacy. — 1998. — 24. — (8). — P. 703–727.

13. Recent advances in intraocular drug delivery systems / T. Yasukawa [et al.] // Recent Pat. Drug Deliv. Formul. — 2011. — 5. — P. 1–10.

About this article

Authors: Belyy Yu.A., Yudina Yu.A., Novikov S.V.

Year: 2014

Editor-in-chief

Sergey Aleksandrovich
MIROSHNIKOV

© Электронное периодическое издание: ВЕСТНИК ОГУ on-line (VESTNIK OSU on-line), ISSN on-line 1814-6465
Зарегистрировано в Федеральной службе по надзору в сфере связи, информационных технологий и массовых коммуникаций
Свидетельство о регистрации СМИ: Эл № ФС77-37678 от 29 сентября 2009 г.
Учредитель: Оренбургский государственный университет (ОГУ)
Главный редактор: С.А. Мирошников
Адрес редакции: 460018, г. Оренбург, проспект Победы, д. 13, к. 2335
Тел./факс: (3532)37-27-78 E-mail: vestnik@mail.osu.ru